450.00

MAMGIT-I Tab 10mg (Memantine Hydrochloride 10mg) – 10 Tablets | USP

logo

Out of stock

Description

MAMGIT-I Tab 10mg contains Memantine Hydrochloride 10mg, an NMDA receptor antagonist available in tablet form. According to the attached product packaging, each tablet contains Memantine Hydrochloride and the product is labeled as USP, with 10 tablets per pack. The pack also carries an Rx symbol, indicating that it should be used under appropriate medical supervision.

For customers searching for MAMGIT-I 10mg tablets, Memantine Hydrochloride 10mg tablets, Memantine 10mg USP tablets, or MAMGIT-I Memantine 10mg 10 tablets, this product provides a clearly labeled 10mg strength in a convenient tablet formulation.

Memantine is a prescription medicine commonly used in the management of symptoms associated with certain types of dementia, including moderate to severe Alzheimer’s disease. Use MAMGIT-I 10mg only as prescribed by a qualified healthcare professional. Do not start, stop, or change the dosage without medical advice.

Purpose

MAMGIT-I 10mg provides Memantine Hydrochloride 10mg for patients for whom this medicine and strength have been prescribed by a qualified healthcare professional.

Key Features

  • Brand: MAMGIT-I
  • Active ingredient: Memantine Hydrochloride
  • Strength: 10mg
  • Dosage form: Tablet
  • Pack size: 10 tablets
  • Product specification: USP
  • Drug class: NMDA receptor antagonist
  • Prescription status: Rx
  • Manufacturer: Glitz Pharma

Benefits

  • Provides a standardized 10mg strength of memantine hydrochloride.
  • Convenient tablet dosage form.
  • USP specification indicated on the product packaging.
  • Supplied in a compact 10-tablet pack.

Pros

  • 10mg memantine hydrochloride strength
  • Convenient tablet formulation
  • USP-labeled product
  • 10-tablet pack
  • Clearly labeled prescription medicine

Cons

  • Prescription medicine requiring professional guidance
  • May cause side effects in some individuals
  • May not be suitable for everyone
  • Potential interactions with other medicines should be reviewed by a healthcare professional

Active Ingredient

Memantine Hydrochloride 10mg

Dosage Form

Tablet

Pack Size

10 Tablets

Drug Class

NMDA Receptor Antagonist

Manufacturer

Glitz Pharma

Storage Instructions

Store according to the instructions provided on the product packaging. Keep out of reach of children and protect the medicine from excessive heat, moisture, and direct sunlight.

Precautions

Use MAMGIT-I 10mg only under the direction of a qualified healthcare professional. Inform your doctor or pharmacist about other medicines, supplements, kidney problems, or other relevant medical conditions before use. Do not change the prescribed dose or discontinue treatment without professional medical advice.

Product Specifications

Specification Details
Product Name MAMGIT-I Tab 10mg
Active Ingredient Memantine Hydrochloride
Strength 10mg
Form Tablet
Pack Size 10 Tablets
Specification USP
Drug Class NMDA Receptor Antagonist
Prescription Status Rx
Manufacturer Glitz Pharma

Brand

GLITZ PHARMA

Introducing Glitz Pharma – your trusted partner in advancing health through innovation, quality, and care.At Glitz Pharma, we specialize in producing high-quality pharmaceutical products that combine scientific excellence with a commitment to global health standards. We believe in modernizing healthcare while preserving the integrity and values that form the foundation of effective medicine. With a strong foundation in GMP-certified manufacturing and a growing global footprint, Glitz Pharma continues to deliver consistent value in the ever-evolving world of healthcare.As a leading pharmaceutical manufacturer and distributor, we are dedicated to offering reliable, accessible, and safe medical solutions through our expansive Pharma Services Distribution—reaching patients and healthcare providers across multiple regions.
logo

Reviews

There are no reviews yet.

Be the first to review “MAMGIT-I Tab 10mg (Memantine Hydrochloride 10mg) – 10 Tablets | USP”

Your email address will not be published. Required fields are marked *